EPRX · Eupraxia Pharmaceuticals Inc.
Market Cap
$441.04M
Shares
66.07M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.68
Open$7.38
Day$6.67–7.45
52W close$5.27–9.07
Avg vol 30d385K
Short int6.3M · 9.6% float · 28.8d
Short vol51%
DataApr 2024–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−6%
below
Price vs 50-day avg
+1%
above
RSI (14)
48
neutral
MACD trend
Positive
52-week position
37%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
−15%
trailing
YTD return
−12%
this year
Relative strength
−28%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+24% holders QoQ · +18 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.59% of float · ▲ +4.9% MoM · 28.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
68 holders — near 2-yr high, broad support
Squeeze score
83
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
63%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
5.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−6%
Bearish
Price vs 50-day avg
+1%
Bullish
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
37%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+24% holders QoQ · +18 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.59% of float · ▲ +4.9% MoM · 28.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
68 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $5
Now $7 · 37%
Range high $9
vs 200-day avg -6%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EPRX
this stock
Eupraxia Pharmaceuticals Inc.
|
$441.04M | -11.6% | — | — | 9.6% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +19.5% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +2.9% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$63.63B | +21.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.23B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EPRX | -0.8% | +4.3% | -14.6% | +4.3% | -11.6% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -1.3% | +1.3% | -28.1% | +1.3% | -24.4% |
Key facts
CIK
1581178
CUSIP
29842P105
13F (30d)
68 filings
66 filers
Visit website
Investor relations